Activation of the tumor suppressor protein p53 can lead to arrest in both G 1 and G 2 stages of the cell cycle and, in some cells, to apoptotic cell death. In this study, we showed that the p53 response to a chemotherapeutic drug, actinomycin D, was reversible in both normal and tumor cells, even wh
The magnitude of methylmercury-induced cytotoxicity and cell cycle arrest is p53-dependent
โ Scribed by Elizabeth J. Gribble; Sung-Woo Hong; Elaine M. Faustman
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 395 KB
- Volume
- 73
- Category
- Article
- ISSN
- 1542-0752
No coin nor oath required. For personal study only.
โฆ Synopsis
BACKGROUND: Methylmercury (MeHg), a ubiquitous environmental contaminant, is a known potent teratogen selectively affecting the developing central nervous system. While a definitive mechanism for MeHginduced developmental neurotoxicity remains elusive, in utero exposure has been associated with reduced brain weight and reduction in cell number. This suggests early toxicant interference with critical molecular signaling events controlling cell behavior, i.e., proliferation. METHODS: To examine the role of p53, a major regulator of the G 1 /S and G 2 /M cell cycle checkpoints, in MeHg toxicity, we isolated GD 14 primary embryonal fibroblasts from homozygous wild-type p53 (p53ฯฉ/ฯฉ) and homozygous null p53 (p53-/-) mice. Cells were treated at passages 4 -7 for 24 or 48 hr with 0, 1.0, or 2.5 M MeHg and analyzed for effects on viability, cell cycle progression (using BrdU-Hoechst flow cytometric analysis), and apoptosis via annexin V-FITC and propidium iodide (PI) staining. RESULTS: The p53ฯฉ/ฯฉ cells are more sensitive than p53-/-cells to MeHginduced cytotoxicity, cell cycle inhibition, and induction of apoptosis: at 24 hr, 2.5 M MeHg reduced p53ฯฉ/ฯฉ cell viability to 72.6% ฯฎ 3.2%, while p53-/-viability was 94.6% ฯฎ 0.4%. The p53-/-cells underwent less necrosis and less apoptosis following MeHg treatment. MeHg (2.5 M) also halted all cycling in the p53ฯฉ/ฯฉ cells, while 42.6% ฯฎ 7.2% of p53-/-cells were able to reach a new G 0 /G 1 in 48 hr. Time-and dose-dependent accumulation of cells in G 2 /M phase (1.0 and 2.5 M MeHg) was observed independent of the p53 genotype; however, the magnitude of change was p53-dependent. CONCLUSIONS: These studies suggest that MeHginduced cell cycle arrest occurs via both p53-dependent and -independent pathways in our model system; however, cell death resulting from MeHg exposure is highly dependent on p53.
๐ SIMILAR VOLUMES
Oligodendrocyte differentiation is accompanied by dramatic changes in gene expression as well as cell cycle arrest. To determine whether cell cycle arrest is sufficient to induce the changes in cell phenotype associated with differentiation, we inhibited oligodendrocyte precursor proliferation in vi
The von Hippel-Lindau gene product (pVHL) interacts with and inhibits the cellular transcription factor elongin. However, the subcellular localization of pVHL has remained uncertain. Naturally occurring pVHL mutants which fail to interact with elongin have been described in patients with VHL disease
Background: Paclitaxel (Taxol) is known to act mainly in mitosis, interfering with microtubule dynamics, but effects on the other cells cycle phases have been reported also. However, a comparative picture of perturbation and killing in the G 1 , S and G 2 M phases after drug treatment is lacking. Th
## Abstract When treated with the steroid hormone 20โhydroxyecdysone (20E), C7โ10 cells from the mosquito, __Aedes albopictus__, arrest in the G1 phase of the cell cycle. To explore whether 20Eโmediated cell cycle arrest proceeds through increased levels of cell cycle inhibitor (CKI) proteins, we c